
Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma
Author(s) -
Cristina Fernández Pérez,
Julia González-Rincón,
Arantza Onaindía,
Carmen Almaráz,
Nuria GarcíaDíaz,
Helena Pisonero,
Soraya Curiel-Olmo,
Sagrario Gómez,
Laura Cereceda,
Rebeca Madureira,
Dolores Suárez-Massa,
José L. Rodríguez-Peralto,
C. Postigo,
Alicia LeónCastillo,
Carmen González-Vela,
Nerea Martínez,
Pablo L. OrtizRomero,
Margarita SánchezBeato,
Miguel Á. Piris,
Jose P. Vaqué
Publication year - 2015
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2015.132837
Subject(s) - stat , cancer research , jak stat signaling pathway , lymphoma , kinase , janus kinase , medicine , signal transduction , biology , immunology , receptor tyrosine kinase , microbiology and biotechnology , stat3